Radius Health, Inc. (RDUS)
USD 28.22
(-2.49%)
USD 28.22
(-2.49%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.71 Billion USD | -6.06% |
| 2022 | 1.82 Billion USD | 22.23% |
| 2021 | 1.49 Billion USD | 21.5% |
| 2020 | 1.22 Billion USD | 461.22% |
| 2019 | 219.15 Million USD | -23.63% |
| 2018 | 286.96 Million USD | -37.84% |
| 2017 | 461.65 Million USD | 35.67% |
| 2016 | 340.28 Million USD | -29.47% |
| 2015 | 482.46 Million USD | 345.01% |
| 2014 | 108.41 Million USD | 749.8% |
| 2013 | 12.75 Million USD | -49.57% |
| 2012 | 25.3 Million USD | -60.24% |
| 2011 | 63.63 Million USD | 63636900.0% |
| 2010 | 100.00 USD | 0.0% |
| 2009 | 100.00 USD | 100.0% |
| 2008 | -2.25 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 1.86 Billion USD | 4.79% |
| 2023 Q1 | 1.78 Billion USD | -2.28% |
| 2023 Q4 | 1.69 Billion USD | -1.36% |
| 2023 Q3 | 1.71 Billion USD | -8.06% |
| 2023 FY | 1.71 Billion USD | -6.06% |
| 2022 Q1 | 154.14 Million USD | -15.09% |
| 2022 Q3 | 1.82 Billion USD | 1082.72% |
| 2022 Q4 | 1.82 Billion USD | -0.22% |
| 2022 FY | 1.82 Billion USD | 22.23% |
| 2022 Q2 | 154.44 Million USD | 0.19% |
| 2021 Q2 | 192.86 Million USD | -5.97% |
| 2021 Q4 | 181.54 Million USD | -2.49% |
| 2021 Q3 | 186.18 Million USD | -3.46% |
| 2021 Q1 | 205.1 Million USD | 7.06% |
| 2021 FY | 1.49 Billion USD | 21.5% |
| 2020 FY | 1.22 Billion USD | 461.22% |
| 2020 Q2 | 175.09 Million USD | -13.14% |
| 2020 Q3 | 195.95 Million USD | 11.91% |
| 2020 Q4 | 191.58 Million USD | -2.23% |
| 2020 Q1 | 201.58 Million USD | -8.02% |
| 2019 Q3 | 227.49 Million USD | -6.88% |
| 2019 Q2 | 244.29 Million USD | -7.77% |
| 2019 Q4 | 219.15 Million USD | -3.67% |
| 2019 Q1 | 264.86 Million USD | -7.7% |
| 2019 FY | 219.15 Million USD | -23.63% |
| 2018 Q3 | 319.4 Million USD | -10.6% |
| 2018 FY | 286.96 Million USD | -37.84% |
| 2018 Q1 | 404 Million USD | -12.49% |
| 2018 Q2 | 357.28 Million USD | -11.56% |
| 2018 Q4 | 286.96 Million USD | -10.16% |
| 2017 Q2 | 239.42 Million USD | -18.94% |
| 2017 Q1 | 295.35 Million USD | -13.2% |
| 2017 FY | 461.65 Million USD | 35.67% |
| 2017 Q4 | 461.65 Million USD | -8.93% |
| 2017 Q3 | 506.93 Million USD | 111.73% |
| 2016 FY | 340.28 Million USD | -29.47% |
| 2016 Q1 | 445.09 Million USD | -7.75% |
| 2016 Q4 | 340.28 Million USD | -10.0% |
| 2016 Q3 | 378.1 Million USD | -7.66% |
| 2016 Q2 | 409.44 Million USD | -8.01% |
| 2015 Q4 | 482.46 Million USD | -4.74% |
| 2015 Q3 | 506.47 Million USD | 121.87% |
| 2015 FY | 482.46 Million USD | 345.01% |
| 2015 Q1 | 246.69 Million USD | 127.54% |
| 2015 Q2 | 228.27 Million USD | -7.46% |
| 2014 Q3 | 70.93 Million USD | -12.57% |
| 2014 Q2 | 81.13 Million USD | 154.28% |
| 2014 Q1 | 31.9 Million USD | 150.09% |
| 2014 FY | 108.41 Million USD | 749.8% |
| 2014 Q4 | 108.41 Million USD | 52.84% |
| 2013 Q1 | 14.8 Million USD | -41.49% |
| 2013 Q3 | 30.12 Million USD | -30.71% |
| 2013 Q4 | 12.75 Million USD | -57.64% |
| 2013 FY | 12.75 Million USD | -49.57% |
| 2013 Q2 | 43.46 Million USD | 193.66% |
| 2012 Q2 | 51.96 Million USD | -1.1% |
| 2012 Q3 | 39.56 Million USD | -23.86% |
| 2012 Q4 | 25.3 Million USD | -36.06% |
| 2012 FY | 25.3 Million USD | -60.24% |
| 2012 Q1 | 52.54 Million USD | -17.42% |
| 2011 Q4 | 63.63 Million USD | 172.08% |
| 2011 Q3 | 23.38 Million USD | -18.77% |
| 2011 Q2 | 28.79 Million USD | 28792900.0% |
| 2011 Q1 | 100.00 USD | 0.0% |
| 2011 FY | 63.63 Million USD | 63636900.0% |
| 2010 Q2 | 100.00 USD | -94.94% |
| 2010 FY | 100.00 USD | 0.0% |
| 2010 Q4 | 100.00 USD | -94.94% |
| 2010 Q3 | 1975.00 USD | 1875.0% |
| 2010 Q1 | 1975.00 USD | 1875.0% |
| 2009 Q3 | 1975.00 USD | 1875.0% |
| 2009 Q2 | 100.00 USD | -93.75% |
| 2009 Q1 | 1600.00 USD | 100.07% |
| 2009 FY | 100.00 USD | 100.0% |
| 2009 Q4 | 100.00 USD | -94.94% |
| 2008 Q4 | -2.25 Million USD | -137.07% |
| 2008 Q2 | 21.51 Million USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | -2.25 Million USD | 0.0% |
| 2008 Q3 | 6.07 Million USD | -71.76% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Cosmos Health Inc. | 66.29 Million USD | -2488.331% |
| Safety Shot Inc | 12.7 Million USD | -13401.65% |
| Bright Green Corporation | 17.4 Million USD | -9760.049% |
| Embecta Corp. | 1.21 Billion USD | -41.3% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | -89.729% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | -2888.521% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | -50.086% |
| Dynavax Technologies Corporation | 997.09 Million USD | -72.095% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | -733.811% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | -135.612% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | -8.992% |
| PainReform Ltd. | 9.93 Million USD | -17180.453% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -6174.734% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -6174.734% |
| SCYNEXIS, Inc. | 128.41 Million USD | -1236.284% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -7319.66% |
| Journey Medical Corporation | 76.84 Million USD | -2132.884% |
| Alpha Teknova, Inc. | 128.58 Million USD | -1234.465% |
| Procaps Group, S.A. | 460.18 Million USD | -272.881% |
| Theratechnologies Inc. | 77.76 Million USD | -2106.469% |
| Harrow Health, Inc. | 311.75 Million USD | -450.416% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -11421.849% |
| Biofrontera Inc. | 27.93 Million USD | -6043.309% |
| DURECT Corporation | 45.18 Million USD | -3697.271% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | -21.787% |
| Cronos Group Inc. | 1.13 Billion USD | -51.285% |
| OptiNose, Inc. | 107.72 Million USD | -1492.839% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | -264.264% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -2966.988% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -7345.389% |
| Organogenesis Holdings Inc. | 460.02 Million USD | -273.012% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -14297.747% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | -1998.351% |
| Universe Pharmaceuticals INC | 53.28 Million USD | -3120.2% |
| ProPhase Labs, Inc. | 91.92 Million USD | -1766.643% |
| Phibro Animal Health Corporation | 982.18 Million USD | -74.707% |
| Procaps Group S.A. | 460.18 Million USD | -272.881% |
| Alvotech | 950.09 Million USD | -80.609% |
| TherapeuticsMD, Inc. | 43.3 Million USD | -3862.107% |
| Viatris Inc. | 47.68 Billion USD | 96.402% |
| Rockwell Medical, Inc. | 52.17 Million USD | -3188.96% |
| Aytu BioPharma, Inc. | 118.09 Million USD | -1353.024% |
| SIGA Technologies, Inc. | 254.83 Million USD | -573.354% |
| Tilray Brands, Inc. | 4.33 Billion USD | 60.419% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | -526.941% |
| Shineco, Inc. | 84.17 Million USD | -1938.443% |
| PetIQ, Inc. | 868.22 Million USD | -97.639% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -20235.46% |
| Incannex Healthcare Limited | 17.04 Million USD | -9965.988% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 47.224% |
| Alimera Sciences, Inc. | 153.52 Million USD | -1017.707% |
| Silver Spike Investment Corp. | 88.57 Million USD | -1837.256% |
| Assertio Holdings, Inc. | 286.41 Million USD | -499.104% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -28731.067% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | -4977.404% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | -5392.267% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -12852.965% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | -557.134% |
| Hempacco Co., Inc. | 18.04 Million USD | -9410.289% |
| Talphera, Inc. | 20.39 Million USD | -8313.577% |
| Alvotech | 950.09 Million USD | -80.609% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | -322.481% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | -3.925% |
| Currenc Group, Inc. | 141.49 Million USD | -1112.767% |
| Kamada Ltd. | 351.96 Million USD | -387.527% |
| Indivior PLC | 1.95 Billion USD | 12.059% |
| Evoke Pharma, Inc. | 7.06 Million USD | -24175.841% |
| Flora Growth Corp. | 23.62 Million USD | -7162.969% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -12852.965% |
| Evolus, Inc. | 188.99 Million USD | -807.919% |
| HUTCHMED (China) Limited | 1.27 Billion USD | -34.082% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | -13.42% |
| Akanda Corp. | 8.83 Million USD | -19311.203% |